Knuff & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.23M | Buy |
17,641
+2,845
| +19% | +$375K | 0.56% | 38 |
|
|
2026
Q1 | $2.06M | Buy |
14,796
+400
| +3% | +$56K | 0.62% | 36 |
|
|
2025
Q4 | $1.77M | Hold |
14,396
| – | – | 0.52% | 36 |
|
|
2025
Q3 | $1.6M | Buy |
14,396
+2,034
| +16% | +$231K | 0.46% | 42 |
|
|
2025
Q2 | $1.37M | Hold |
12,362
| – | – | 0.43% | 40 |
|
|
2025
Q1 | $1.39M | Sell |
12,362
-200
| -2% | -$20.6K | 0.46% | 40 |
|
|
2024
Q4 | $1.16M | Sell |
12,562
-714
| -5% | -$64.3K | 0.35% | 54 |
|
|
2024
Q3 | $1.11M | Buy |
13,276
+30
| +0.2% | +$2.29K | 0.34% | 56 |
|
|
2024
Q2 | $909K | Sell |
13,246
-5,325
| -29% | -$355K | 0.3% | 56 |
|
|
2024
Q1 | $1.36M | Sell |
18,571
-500
| -3% | -$38.4K | 0.46% | 49 |
|
|
2023
Q4 | $1.54M | Sell |
19,071
-3,800
| -17% | -$296K | 0.56% | 42 |
|
|
2023
Q3 | $1.71M | Sell |
22,871
-200
| -0.9% | -$15.4K | 0.68% | 40 |
|
|
2023
Q2 | $1.78M | Sell |
23,071
-600
| -3% | -$47.9K | 0.67% | 42 |
|
|
2023
Q1 | $1.96M | Sell |
23,671
-335
| -1% | -$27.7K | 0.78% | 36 |
|
|
2022
Q4 | $2.06M | Hold |
24,006
| – | – | 0.88% | 34 |
|
|
2022
Q3 | $1.48M | Buy |
24,006
+895
| +4% | +$56.4K | 0.7% | 39 |
|
|
2022
Q2 | $1.43M | Sell |
23,111
-1,100
| -5% | -$68.1K | 0.64% | 43 |
|
|
2022
Q1 | $1.44M | Sell |
24,211
-13,195
| -35% | -$843K | 0.52% | 50 |
|
|
2021
Q4 | $2.72M | Sell |
37,406
-2,170
| -5% | -$149K | 0.84% | 34 |
|
|
2021
Q3 | $2.76M | Sell |
39,576
-1,075
| -3% | -$75.5K | 1.03% | 32 |
|
|
2021
Q2 | $2.8M | Sell |
40,651
-450
| -1% | -$30K | 1.04% | 33 |
|
|
2021
Q1 | $2.66M | Sell |
41,101
-3,070
| -7% | -$198K | 1.14% | 33 |
|
|
2020
Q4 | $2.57M | Sell |
44,171
-880
| -2% | -$53.1K | 1.06% | 31 |
|
|
2020
Q3 | $2.85M | Buy |
45,051
+2,645
| +6% | +$183K | 1.34% | 25 |
|
|
2020
Q2 | $3.26M | Buy |
42,406
+2,226
| +6% | +$171K | 1.79% | 16 |
|
|
2020
Q1 | $3M | Buy |
40,180
+5,315
| +15% | +$367K | 2.18% | 14 |
|
|
2019
Q4 | $2.27M | Buy |
34,865
+555
| +2% | +$36.1K | 1.36% | 21 |
|
|
2019
Q3 | $2.17M | Buy |
34,310
+770
| +2% | +$50.3K | 1.49% | 19 |
|
|
2019
Q2 | $2.27M | Buy |
33,540
+1,625
| +5% | +$107K | 1.61% | 18 |
|
|
2019
Q1 | $2.08M | Buy |
31,915
+680
| +2% | +$45.2K | 1.59% | 18 |
|
|
2018
Q4 | $1.95M | Buy |
+31,235
| New | +$2.18M | 1.92% | 13 |
|
Other funds holding GILD
Knuff & Co's GILD Position: Q2 2026 in Review
Knuff & Co increased its Gilead Sciences (GILD) stake by 19% in Q2 2026, buying an estimated $375K and bringing the position to 17,641 shares worth $2.23M. The position accounts for 0.56% of the portfolio, ranked #38.
Knuff & Co first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.26M in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Knuff & Co held 17,641 shares of Gilead Sciences worth $2.23M as of Q2 2026.
- Knuff & Co bought 2,845 Gilead Sciences shares in Q2 2026, an estimated $375K.
- Gilead Sciences made up 0.56% of Knuff & Co's portfolio in Q2 2026, its #38 holding.
- Knuff & Co first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
- Knuff & Co's Gilead Sciences position peaked at $3.26M in Q2 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Knuff & Co's 13F filing for Q2 2026, filed 10 Aug 2026.